← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2018Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT04150835CollaboratorPhase 4Nov 30, 2019
- NCT03588429Overall official - principal investigatorPhase 3Oct 1, 2018
- NCT03588429Lead sponsorPhase 3Oct 1, 2018
Details
- Last known activity
- Sep 1, 2025